Therefore, the negative regulation of GLS protein levels and activity by ERK5 could be unexpected at first sight; however, more studies are needed in order to understand whether or not this novel interaction between ERK5 and GLS will be another adaptive mechanism of cancer cells to fine-tune and modulate glutaminolysis and glycolysis routes to sustain their growth and proliferation programs. This evidence concerns the gene MAPK7 and cancer.